Clinical Trials in Pittsburgh

Showing 18821-18840 of 21,047 trials

Therapy for Depression With Co-occurring Panic or Anxiety Symptoms

NCT00051207

This 6-month study, with a 3-month follow up period, will compare the effectiveness of new and traditional psychotherapies for depression with panic or anxiety symptoms.

DepressionAnxiety DisordersPanic Disorder

University of Pittsburgh36 participantsStarted Nov 2002

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder

NCT00178061

This study will examine the impact of comorbid personality disorder on the outcome of treatment among patients with bipolar I disorder.

Bipolar I DisorderBorderline Personality Disorder

University of Pittsburgh13 participantsStarted Aug 1997

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

NCT00023725

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if radiation therapy is more effective with or without SU5416 in treating soft tissue sarcoma. PURPOSE: Phase I/II trial to compare the effectiveness of radiation therapy with or without SU5416 in treating patients who have stage IB or stage IIA soft tissue sarcoma.

Sarcoma

Radiation Therapy Oncology GroupStarted Aug 2001

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Huntsville, Alabama, United States +223 more locations

Therapy for Depression With Co-occurring Panic or Anxiety Symptoms

Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Find Trials by Condition in Pittsburgh

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione